measure,location,sex,age,cause,metric,year,val,upper,lower
Prevalence,United States,Male,10 to 14,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,10 to 14,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,15 to 19,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,15 to 19,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,20 to 24,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,20 to 24,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,25 to 29,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,25 to 29,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,30 to 34,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,30 to 34,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,35 to 39,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,35 to 39,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,40 to 44,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,40 to 44,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,45 to 49,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,45 to 49,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,50 to 54,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,50 to 54,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,55 to 59,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,55 to 59,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,60 to 64,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,60 to 64,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,65 to 69,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,65 to 69,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,70 to 74,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,70 to 74,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,75 to 79,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,75 to 79,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,80 plus,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Female,80 plus,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,United States,Male,10 to 14,Lower respiratory infections,Percent,2017,0.000724602117922,0.00100299174489,0.00050388914507
Prevalence,United States,Female,10 to 14,Lower respiratory infections,Percent,2017,0.00065098042678,0.000902205144554,0.00044911834277
Prevalence,United States,Male,15 to 19,Lower respiratory infections,Percent,2017,0.000553149412685,0.00066681254706,0.000444887857916
Prevalence,United States,Female,15 to 19,Lower respiratory infections,Percent,2017,0.000613643641205,0.000741222778533,0.00049550093993
Prevalence,United States,Male,20 to 24,Lower respiratory infections,Percent,2017,0.000504164377006,0.0006210337444,0.000395674820821
Prevalence,United States,Female,20 to 24,Lower respiratory infections,Percent,2017,0.000654123310913,0.000795828750281,0.00052114311336
Prevalence,United States,Male,25 to 29,Lower respiratory infections,Percent,2017,0.000569481923335,0.000651103113493,0.000495174694608
Prevalence,United States,Female,25 to 29,Lower respiratory infections,Percent,2017,0.000740551433371,0.000846307012731,0.00064898415352
Prevalence,United States,Male,30 to 34,Lower respiratory infections,Percent,2017,0.0006406236994,0.000714582580715,0.000570515478725
Prevalence,United States,Female,30 to 34,Lower respiratory infections,Percent,2017,0.000830310146649,0.000927091345823,0.000741604905847
Prevalence,United States,Male,35 to 39,Lower respiratory infections,Percent,2017,0.000714864347556,0.000817775712681,0.000623379159966
Prevalence,United States,Female,35 to 39,Lower respiratory infections,Percent,2017,0.000922323156377,0.00105389149786,0.000801778708302
Prevalence,United States,Male,40 to 44,Lower respiratory infections,Percent,2017,0.000780371989569,0.000891677078489,0.000681630652766
Prevalence,United States,Female,40 to 44,Lower respiratory infections,Percent,2017,0.000999832330581,0.00114299309137,0.000864266649757
Prevalence,United States,Male,45 to 49,Lower respiratory infections,Percent,2017,0.000832502381226,0.000919023820093,0.000755807613084
Prevalence,United States,Female,45 to 49,Lower respiratory infections,Percent,2017,0.0010578785365,0.00116734734777,0.000954723645128
Prevalence,United States,Male,50 to 54,Lower respiratory infections,Percent,2017,0.000884730332343,0.00097703396,0.00080503739722
Prevalence,United States,Female,50 to 54,Lower respiratory infections,Percent,2017,0.00111751481376,0.00123180635974,0.00101160014318
Prevalence,United States,Male,55 to 59,Lower respiratory infections,Percent,2017,0.000938068704554,0.0010504361858,0.000823198199213
Prevalence,United States,Female,55 to 59,Lower respiratory infections,Percent,2017,0.00117773366704,0.00131101139824,0.00103606774821
Prevalence,United States,Male,60 to 64,Lower respiratory infections,Percent,2017,0.00105747480655,0.00117664087279,0.000935537560299
Prevalence,United States,Female,60 to 64,Lower respiratory infections,Percent,2017,0.00125529414819,0.00139565788619,0.00110762813767
Prevalence,United States,Male,65 to 69,Lower respiratory infections,Percent,2017,0.00126663428976,0.00136882987095,0.00116262301765
Prevalence,United States,Female,65 to 69,Lower respiratory infections,Percent,2017,0.00135696736865,0.0014670355478,0.00124382118301
Prevalence,United States,Male,70 to 74,Lower respiratory infections,Percent,2017,0.00147580878049,0.00160881272944,0.00133765965818
Prevalence,United States,Female,70 to 74,Lower respiratory infections,Percent,2017,0.00145749353698,0.00157986465546,0.00133738081661
Prevalence,United States,Male,75 to 79,Lower respiratory infections,Percent,2017,0.00168399152702,0.00188256619545,0.00149194466465
Prevalence,United States,Female,75 to 79,Lower respiratory infections,Percent,2017,0.00155865822381,0.00173691057742,0.00139081517001
Prevalence,United States,Male,80 plus,Lower respiratory infections,Percent,2017,0.00240100978125,0.00261693579522,0.00221686750214
Prevalence,United States,Female,80 plus,Lower respiratory infections,Percent,2017,0.00210761598128,0.00228967811303,0.00194264912956
Prevalence,United States,Male,10 to 14,Upper respiratory infections,Percent,2017,0.0465478596284,0.0633189744473,0.0305414620039
Prevalence,United States,Female,10 to 14,Upper respiratory infections,Percent,2017,0.0480374551398,0.0645944278113,0.0313788257377
Prevalence,United States,Male,15 to 19,Upper respiratory infections,Percent,2017,0.0390863733948,0.0537941675557,0.0271894083891
Prevalence,United States,Female,15 to 19,Upper respiratory infections,Percent,2017,0.0450151719424,0.0613160603049,0.0316747755557
Prevalence,United States,Male,20 to 24,Upper respiratory infections,Percent,2017,0.0374021626347,0.0515940635296,0.0260405817363
Prevalence,United States,Female,20 to 24,Upper respiratory infections,Percent,2017,0.0445474092729,0.0603771072864,0.0312304617869
Prevalence,United States,Male,25 to 29,Upper respiratory infections,Percent,2017,0.0376262215102,0.0512717510195,0.0266101549847
Prevalence,United States,Female,25 to 29,Upper respiratory infections,Percent,2017,0.0424491737476,0.0585952935553,0.0296509508166
Prevalence,United States,Male,30 to 34,Upper respiratory infections,Percent,2017,0.0370793725405,0.0492512004541,0.0258104252516
Prevalence,United States,Female,30 to 34,Upper respiratory infections,Percent,2017,0.0427823121179,0.0568681425004,0.0297996203733
Prevalence,United States,Male,35 to 39,Upper respiratory infections,Percent,2017,0.0375477133119,0.0515292800739,0.0269722503639
Prevalence,United States,Female,35 to 39,Upper respiratory infections,Percent,2017,0.0438525403208,0.0603510994986,0.0315452898564
Prevalence,United States,Male,40 to 44,Upper respiratory infections,Percent,2017,0.0367065174809,0.0498755181156,0.0255729303829
Prevalence,United States,Female,40 to 44,Upper respiratory infections,Percent,2017,0.0401478605536,0.0552426190289,0.0275906301945
Prevalence,United States,Male,45 to 49,Upper respiratory infections,Percent,2017,0.0341645935862,0.0496640575026,0.0236508276852
Prevalence,United States,Female,45 to 49,Upper respiratory infections,Percent,2017,0.0369034620028,0.0536243980437,0.0257249900377
Prevalence,United States,Male,50 to 54,Upper respiratory infections,Percent,2017,0.0330309327121,0.0449326322229,0.0228622654941
Prevalence,United States,Female,50 to 54,Upper respiratory infections,Percent,2017,0.0359138236662,0.0489321041293,0.0251750294399
Prevalence,United States,Male,55 to 59,Upper respiratory infections,Percent,2017,0.0328317562306,0.0455566317217,0.0228807913601
Prevalence,United States,Female,55 to 59,Upper respiratory infections,Percent,2017,0.0343604036999,0.0477180645824,0.0237324660713
Prevalence,United States,Male,60 to 64,Upper respiratory infections,Percent,2017,0.0306087766341,0.0417998627545,0.0200741600364
Prevalence,United States,Female,60 to 64,Upper respiratory infections,Percent,2017,0.0302119983392,0.0410976429779,0.0203721458056
Prevalence,United States,Male,65 to 69,Upper respiratory infections,Percent,2017,0.0292581281722,0.0410046754178,0.0203896752912
Prevalence,United States,Female,65 to 69,Upper respiratory infections,Percent,2017,0.0269612706025,0.038269753907,0.0185761810641
Prevalence,United States,Male,70 to 74,Upper respiratory infections,Percent,2017,0.0274037664941,0.0390499108792,0.0191824905065
Prevalence,United States,Female,70 to 74,Upper respiratory infections,Percent,2017,0.0250631091795,0.0356475810455,0.0176420518036
Prevalence,United States,Male,75 to 79,Upper respiratory infections,Percent,2017,0.0245751305895,0.0355195840084,0.016369461124
Prevalence,United States,Female,75 to 79,Upper respiratory infections,Percent,2017,0.0232846561641,0.0333867535618,0.0155512591238
Prevalence,United States,Male,80 plus,Upper respiratory infections,Percent,2017,0.024759767419,0.0315252507413,0.019032555443
Prevalence,United States,Female,80 plus,Upper respiratory infections,Percent,2017,0.021893887031,0.0278221558908,0.0169203995648
Prevalence,United States,Male,10 to 14,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Hypertensive heart disease,Percent,2017,5.64171358096e-07,9.76797767764e-07,2.7016881232e-07
Prevalence,United States,Female,15 to 19,Hypertensive heart disease,Percent,2017,5.52893912378e-07,9.49104086305e-07,2.61844774688e-07
Prevalence,United States,Male,20 to 24,Hypertensive heart disease,Percent,2017,5.42708243085e-05,7.64309093807e-05,3.71822153979e-05
Prevalence,United States,Female,20 to 24,Hypertensive heart disease,Percent,2017,5.63631487295e-05,8.01744843136e-05,3.83653984487e-05
Prevalence,United States,Male,25 to 29,Hypertensive heart disease,Percent,2017,0.000189156591407,0.00026113386994,0.00013001297844
Prevalence,United States,Female,25 to 29,Hypertensive heart disease,Percent,2017,0.000232398100718,0.000318724460165,0.000157387187653
Prevalence,United States,Male,30 to 34,Hypertensive heart disease,Percent,2017,0.000401439953802,0.00051214302826,0.00029999530676
Prevalence,United States,Female,30 to 34,Hypertensive heart disease,Percent,2017,0.000478654414228,0.00061722838342,0.000357144633095
Prevalence,United States,Male,35 to 39,Hypertensive heart disease,Percent,2017,0.000675690658108,0.000866330509751,0.000500098646391
Prevalence,United States,Female,35 to 39,Hypertensive heart disease,Percent,2017,0.000685503387998,0.000884402598616,0.000511592997357
Prevalence,United States,Male,40 to 44,Hypertensive heart disease,Percent,2017,0.00103608681753,0.00131907404706,0.000784987754215
Prevalence,United States,Female,40 to 44,Hypertensive heart disease,Percent,2017,0.000963590686012,0.00123520106902,0.000730488747297
Prevalence,United States,Male,45 to 49,Hypertensive heart disease,Percent,2017,0.00199676710439,0.00248020720533,0.00155475442044
Prevalence,United States,Female,45 to 49,Hypertensive heart disease,Percent,2017,0.00178481744756,0.00220792964261,0.00141813035117
Prevalence,United States,Male,50 to 54,Hypertensive heart disease,Percent,2017,0.00312261908721,0.00393183380175,0.00237090729509
Prevalence,United States,Female,50 to 54,Hypertensive heart disease,Percent,2017,0.00268683161794,0.00330682694638,0.00208904292742
Prevalence,United States,Male,55 to 59,Hypertensive heart disease,Percent,2017,0.00419991666112,0.00534430904342,0.00319108022804
Prevalence,United States,Female,55 to 59,Hypertensive heart disease,Percent,2017,0.00332849470661,0.00415734705915,0.00257162844426
Prevalence,United States,Male,60 to 64,Hypertensive heart disease,Percent,2017,0.00562073008118,0.00755645597867,0.00392434764474
Prevalence,United States,Female,60 to 64,Hypertensive heart disease,Percent,2017,0.00449058113565,0.00586767961719,0.00324944684761
Prevalence,United States,Male,65 to 69,Hypertensive heart disease,Percent,2017,0.00707584957857,0.00916313011646,0.00525361226786
Prevalence,United States,Female,65 to 69,Hypertensive heart disease,Percent,2017,0.00663495731171,0.00851670976322,0.00497836858715
Prevalence,United States,Male,70 to 74,Hypertensive heart disease,Percent,2017,0.00814283686252,0.0110968069596,0.00557758158479
Prevalence,United States,Female,70 to 74,Hypertensive heart disease,Percent,2017,0.00900300027721,0.0118950924057,0.00643358233847
Prevalence,United States,Male,75 to 79,Hypertensive heart disease,Percent,2017,0.00958541003367,0.0127113795636,0.00692633771036
Prevalence,United States,Female,75 to 79,Hypertensive heart disease,Percent,2017,0.0124329276258,0.0164088410317,0.00902352383537
Prevalence,United States,Male,80 plus,Hypertensive heart disease,Percent,2017,0.015499972067,0.0202673431717,0.0114253985167
Prevalence,United States,Female,80 plus,Hypertensive heart disease,Percent,2017,0.027896535394,0.0352748608654,0.0212338368798
Prevalence,United States,Male,10 to 14,Chronic obstructive pulmonary disease,Percent,2017,0.0026334939012,0.00288744897672,0.00224162354917
Prevalence,United States,Female,10 to 14,Chronic obstructive pulmonary disease,Percent,2017,0.00233726868726,0.00264387667668,0.00188914454448
Prevalence,United States,Male,15 to 19,Chronic obstructive pulmonary disease,Percent,2017,0.00336266114699,0.00383367292608,0.00287727232272
Prevalence,United States,Female,15 to 19,Chronic obstructive pulmonary disease,Percent,2017,0.00286879733375,0.00333537516675,0.0022978210497
Prevalence,United States,Male,20 to 24,Chronic obstructive pulmonary disease,Percent,2017,0.00420349829657,0.00512001467785,0.00343978814049
Prevalence,United States,Female,20 to 24,Chronic obstructive pulmonary disease,Percent,2017,0.00359301165233,0.0043781855919,0.00286074600045
Prevalence,United States,Male,25 to 29,Chronic obstructive pulmonary disease,Percent,2017,0.00543682933132,0.00662227066506,0.00436955218893
Prevalence,United States,Female,25 to 29,Chronic obstructive pulmonary disease,Percent,2017,0.00496335062379,0.00607973818231,0.00399792475572
Prevalence,United States,Male,30 to 34,Chronic obstructive pulmonary disease,Percent,2017,0.0074850529593,0.00921676506554,0.0059978206108
Prevalence,United States,Female,30 to 34,Chronic obstructive pulmonary disease,Percent,2017,0.00751986202662,0.00926355699235,0.00601246334747
Prevalence,United States,Male,35 to 39,Chronic obstructive pulmonary disease,Percent,2017,0.0120563154067,0.0143678272495,0.00994397805678
Prevalence,United States,Female,35 to 39,Chronic obstructive pulmonary disease,Percent,2017,0.0136187108668,0.0162937402446,0.0110593460427
Prevalence,United States,Male,40 to 44,Chronic obstructive pulmonary disease,Percent,2017,0.0220072698807,0.0266720796122,0.0180720531796
Prevalence,United States,Female,40 to 44,Chronic obstructive pulmonary disease,Percent,2017,0.0271316028082,0.0327094162683,0.0220594529355
Prevalence,United States,Male,45 to 49,Chronic obstructive pulmonary disease,Percent,2017,0.0400169956785,0.0466820621516,0.0341970482419
Prevalence,United States,Female,45 to 49,Chronic obstructive pulmonary disease,Percent,2017,0.0496114197122,0.057305277467,0.0425828405041
Prevalence,United States,Male,50 to 54,Chronic obstructive pulmonary disease,Percent,2017,0.0663964953162,0.0761074273655,0.0580383270777
Prevalence,United States,Female,50 to 54,Chronic obstructive pulmonary disease,Percent,2017,0.0741616380859,0.0843592189909,0.0656617171835
Prevalence,United States,Male,55 to 59,Chronic obstructive pulmonary disease,Percent,2017,0.0980246613103,0.111178065169,0.0863630417018
Prevalence,United States,Female,55 to 59,Chronic obstructive pulmonary disease,Percent,2017,0.0943258608562,0.106986818461,0.0834103581316
Prevalence,United States,Male,60 to 64,Chronic obstructive pulmonary disease,Percent,2017,0.139649745821,0.158901663494,0.122868310567
Prevalence,United States,Female,60 to 64,Chronic obstructive pulmonary disease,Percent,2017,0.120664439832,0.136080869803,0.106212065652
Prevalence,United States,Male,65 to 69,Chronic obstructive pulmonary disease,Percent,2017,0.201507105894,0.227559048387,0.177783687436
Prevalence,United States,Female,65 to 69,Chronic obstructive pulmonary disease,Percent,2017,0.171425184447,0.193679451732,0.151528514093
Prevalence,United States,Male,70 to 74,Chronic obstructive pulmonary disease,Percent,2017,0.272325040945,0.303055371878,0.244165990309
Prevalence,United States,Female,70 to 74,Chronic obstructive pulmonary disease,Percent,2017,0.232086250647,0.257972034713,0.208641006017
Prevalence,United States,Male,75 to 79,Chronic obstructive pulmonary disease,Percent,2017,0.327401298293,0.359811040629,0.295427496766
Prevalence,United States,Female,75 to 79,Chronic obstructive pulmonary disease,Percent,2017,0.27221540196,0.301308444076,0.244729484189
Prevalence,United States,Male,80 plus,Chronic obstructive pulmonary disease,Percent,2017,0.348507892409,0.38602977105,0.314019987676
Prevalence,United States,Female,80 plus,Chronic obstructive pulmonary disease,Percent,2017,0.278984285606,0.310569213107,0.249723798502
Prevalence,United States,Male,10 to 14,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,15 to 19,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,20 to 24,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,20 to 24,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,25 to 29,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,25 to 29,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,30 to 34,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,30 to 34,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,35 to 39,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,35 to 39,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,40 to 44,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,40 to 44,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,45 to 49,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,45 to 49,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,50 to 54,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,50 to 54,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,55 to 59,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,55 to 59,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,60 to 64,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,60 to 64,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,65 to 69,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,65 to 69,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,70 to 74,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,70 to 74,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,75 to 79,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,75 to 79,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,80 plus,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,80 plus,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,10 to 14,Injuries,Percent,2017,0.08368495392,0.0961167709158,0.0735494091214
Prevalence,United States,Female,10 to 14,Injuries,Percent,2017,0.0772363083162,0.0884452635988,0.0674987452478
Prevalence,United States,Male,15 to 19,Injuries,Percent,2017,0.126975030042,0.143043698539,0.113408960451
Prevalence,United States,Female,15 to 19,Injuries,Percent,2017,0.125816880212,0.152378645049,0.104143206982
Prevalence,United States,Male,20 to 24,Injuries,Percent,2017,0.175710511907,0.195967617559,0.159163046252
Prevalence,United States,Female,20 to 24,Injuries,Percent,2017,0.142183436029,0.167074558315,0.121041263096
Prevalence,United States,Male,25 to 29,Injuries,Percent,2017,0.216361209223,0.239178570941,0.198896320444
Prevalence,United States,Female,25 to 29,Injuries,Percent,2017,0.140659492884,0.156835211876,0.127527597112
Prevalence,United States,Male,30 to 34,Injuries,Percent,2017,0.267649367674,0.291829277518,0.248548881294
Prevalence,United States,Female,30 to 34,Injuries,Percent,2017,0.162795312061,0.178763841935,0.150387216547
Prevalence,United States,Male,35 to 39,Injuries,Percent,2017,0.311409916196,0.338854211698,0.290196248269
Prevalence,United States,Female,35 to 39,Injuries,Percent,2017,0.187466636779,0.202398682429,0.173731613875
Prevalence,United States,Male,40 to 44,Injuries,Percent,2017,0.351424835209,0.38176295849,0.328268840377
Prevalence,United States,Female,40 to 44,Injuries,Percent,2017,0.216002102108,0.235547801945,0.20076708532
Prevalence,United States,Male,45 to 49,Injuries,Percent,2017,0.396308412937,0.430784589105,0.369228299955
Prevalence,United States,Female,45 to 49,Injuries,Percent,2017,0.25383729703,0.28141427314,0.235232701703
Prevalence,United States,Male,50 to 54,Injuries,Percent,2017,0.443485379348,0.480915068314,0.416376777026
Prevalence,United States,Female,50 to 54,Injuries,Percent,2017,0.30077211923,0.331356069922,0.278834195542
Prevalence,United States,Male,55 to 59,Injuries,Percent,2017,0.492767194954,0.533958824277,0.461570395392
Prevalence,United States,Female,55 to 59,Injuries,Percent,2017,0.355629269218,0.39165598927,0.326336924743
Prevalence,United States,Male,60 to 64,Injuries,Percent,2017,0.539528672362,0.582217967155,0.505214858659
Prevalence,United States,Female,60 to 64,Injuries,Percent,2017,0.40980917825,0.450863722806,0.373711849948
Prevalence,United States,Male,65 to 69,Injuries,Percent,2017,0.587295686307,0.635167744232,0.546696155653
Prevalence,United States,Female,65 to 69,Injuries,Percent,2017,0.471627167205,0.522248468084,0.428509843587
Prevalence,United States,Male,70 to 74,Injuries,Percent,2017,0.633620350049,0.687224851471,0.58915961547
Prevalence,United States,Female,70 to 74,Injuries,Percent,2017,0.531215233723,0.596471814001,0.483343494027
Prevalence,United States,Male,75 to 79,Injuries,Percent,2017,0.688993749795,0.742299128915,0.641902641531
Prevalence,United States,Female,75 to 79,Injuries,Percent,2017,0.60617778352,0.675922544084,0.550850957255
Prevalence,United States,Male,80 plus,Injuries,Percent,2017,0.811639967014,0.866365101635,0.768234362541
Prevalence,United States,Female,80 plus,Injuries,Percent,2017,0.762876384546,0.839164606045,0.706433168634
Prevalence,United States,Male,10 to 14,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,15 to 19,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,20 to 24,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,20 to 24,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,25 to 29,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,25 to 29,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,30 to 34,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,30 to 34,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,35 to 39,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,35 to 39,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,40 to 44,Alzheimer's disease and other dementias,Percent,2017,0.00010489246257,0.000138847886929,7.57404435494e-05
Prevalence,United States,Female,40 to 44,Alzheimer's disease and other dementias,Percent,2017,0.00012592822432,0.00016260033659,9.34405892239e-05
Prevalence,United States,Male,45 to 49,Alzheimer's disease and other dementias,Percent,2017,0.000554373587917,0.000705390932234,0.00042711995518
Prevalence,United States,Female,45 to 49,Alzheimer's disease and other dementias,Percent,2017,0.000651227090881,0.000817116361521,0.000512061519736
Prevalence,United States,Male,50 to 54,Alzheimer's disease and other dementias,Percent,2017,0.000967695447597,0.00117731246774,0.000786684923943
Prevalence,United States,Female,50 to 54,Alzheimer's disease and other dementias,Percent,2017,0.0010126064277,0.00122296941655,0.000838682938234
Prevalence,United States,Male,55 to 59,Alzheimer's disease and other dementias,Percent,2017,0.00172123621028,0.00200258919708,0.00144776925316
Prevalence,United States,Female,55 to 59,Alzheimer's disease and other dementias,Percent,2017,0.00160114569137,0.00187780881705,0.00136340380767
Prevalence,United States,Male,60 to 64,Alzheimer's disease and other dementias,Percent,2017,0.00373230857582,0.00443595091536,0.0031449664943
Prevalence,United States,Female,60 to 64,Alzheimer's disease and other dementias,Percent,2017,0.00336050190938,0.00397712239373,0.00283708020715
Prevalence,United States,Male,65 to 69,Alzheimer's disease and other dementias,Percent,2017,0.00841849186363,0.00980652833251,0.00713809448079
Prevalence,United States,Female,65 to 69,Alzheimer's disease and other dementias,Percent,2017,0.00797781151274,0.00934345223896,0.00673545780786
Prevalence,United States,Male,70 to 74,Alzheimer's disease and other dementias,Percent,2017,0.0209786501562,0.0244989673219,0.0179231091908
Prevalence,United States,Female,70 to 74,Alzheimer's disease and other dementias,Percent,2017,0.021369876694,0.024918145641,0.0180233823889
Prevalence,United States,Male,75 to 79,Alzheimer's disease and other dementias,Percent,2017,0.0481021679312,0.0568813371329,0.0405293088744
Prevalence,United States,Female,75 to 79,Alzheimer's disease and other dementias,Percent,2017,0.0523784991134,0.0615685243286,0.0440469822799
Prevalence,United States,Male,80 plus,Alzheimer's disease and other dementias,Percent,2017,0.133696352253,0.151083113359,0.118225931657
Prevalence,United States,Female,80 plus,Alzheimer's disease and other dementias,Percent,2017,0.17433643245,0.195518379972,0.155736619942
Prevalence,United States,Male,10 to 14,Other malignant neoplasms,Percent,2017,0.000806172882277,0.0012552216353,0.000516980426509
Prevalence,United States,Female,10 to 14,Other malignant neoplasms,Percent,2017,0.000763457452325,0.00109827965446,0.000533108928431
Prevalence,United States,Male,15 to 19,Other malignant neoplasms,Percent,2017,0.000785611175564,0.00123164307282,0.0005202449004
Prevalence,United States,Female,15 to 19,Other malignant neoplasms,Percent,2017,0.000783289527413,0.00116635387132,0.000538183134862
Prevalence,United States,Male,20 to 24,Other malignant neoplasms,Percent,2017,0.000927801832452,0.00140424003696,0.000627968900695
Prevalence,United States,Female,20 to 24,Other malignant neoplasms,Percent,2017,0.000964805200513,0.00141596230616,0.000657599983999
Prevalence,United States,Male,25 to 29,Other malignant neoplasms,Percent,2017,0.00182679279674,0.00294606618862,0.00110974837341
Prevalence,United States,Female,25 to 29,Other malignant neoplasms,Percent,2017,0.00156897502298,0.0022833836187,0.00106362905476
Prevalence,United States,Male,30 to 34,Other malignant neoplasms,Percent,2017,0.00219538473408,0.00354642462499,0.00135444466853
Prevalence,United States,Female,30 to 34,Other malignant neoplasms,Percent,2017,0.00189543333436,0.0029187994685,0.00127929218782
Prevalence,United States,Male,35 to 39,Other malignant neoplasms,Percent,2017,0.00139268314494,0.00218234229868,0.000927410687123
Prevalence,United States,Female,35 to 39,Other malignant neoplasms,Percent,2017,0.0014178395364,0.0020907384259,0.000982286740187
Prevalence,United States,Male,40 to 44,Other malignant neoplasms,Percent,2017,0.0010040147713,0.00147348741652,0.000708926884465
Prevalence,United States,Female,40 to 44,Other malignant neoplasms,Percent,2017,0.00128232989159,0.00180952682019,0.000919625880054
Prevalence,United States,Male,45 to 49,Other malignant neoplasms,Percent,2017,0.000488433194063,0.00067303072411,0.000366684332706
Prevalence,United States,Female,45 to 49,Other malignant neoplasms,Percent,2017,0.00101375049907,0.00144672866211,0.000735151672966
Prevalence,United States,Male,50 to 54,Other malignant neoplasms,Percent,2017,0.0004015836974,0.000524043310368,0.000322957811323
Prevalence,United States,Female,50 to 54,Other malignant neoplasms,Percent,2017,0.000585176420826,0.000784253923437,0.000442673074023
Prevalence,United States,Male,55 to 59,Other malignant neoplasms,Percent,2017,0.000538115902066,0.000706744431405,0.000426414149335
Prevalence,United States,Female,55 to 59,Other malignant neoplasms,Percent,2017,0.000607157780783,0.000829443235805,0.000466765799439
Prevalence,United States,Male,60 to 64,Other malignant neoplasms,Percent,2017,0.000588082058239,0.000795130167561,0.000480385363305
Prevalence,United States,Female,60 to 64,Other malignant neoplasms,Percent,2017,0.000814233434188,0.0010274710843,0.000646857696013
Prevalence,United States,Male,65 to 69,Other malignant neoplasms,Percent,2017,0.000807408420878,0.00112948259049,0.000648415685801
Prevalence,United States,Female,65 to 69,Other malignant neoplasms,Percent,2017,0.0010315489312,0.00131753027336,0.000820860846109
Prevalence,United States,Male,70 to 74,Other malignant neoplasms,Percent,2017,0.00122670091852,0.00172035529533,0.000955523084274
Prevalence,United States,Female,70 to 74,Other malignant neoplasms,Percent,2017,0.000881681354127,0.0011002314892,0.000726872602728
Prevalence,United States,Male,75 to 79,Other malignant neoplasms,Percent,2017,0.00145358388295,0.00202064298098,0.00115583681176
Prevalence,United States,Female,75 to 79,Other malignant neoplasms,Percent,2017,0.000971588368508,0.0012080546858,0.000803352951218
Prevalence,United States,Male,80 plus,Other malignant neoplasms,Percent,2017,0.00173669662032,0.00228492692125,0.00138440478464
Prevalence,United States,Female,80 plus,Other malignant neoplasms,Percent,2017,0.00105833693388,0.00129185416289,0.000888677867762
Prevalence,United States,Male,10 to 14,Rheumatic heart disease,Percent,2017,4.96457507573e-05,6.36669823446e-05,3.98240368558e-05
Prevalence,United States,Female,10 to 14,Rheumatic heart disease,Percent,2017,4.89796118375e-05,6.17412647196e-05,3.94828908211e-05
Prevalence,United States,Male,15 to 19,Rheumatic heart disease,Percent,2017,4.81661464924e-05,6.0744075724e-05,3.80950019253e-05
Prevalence,United States,Female,15 to 19,Rheumatic heart disease,Percent,2017,4.79965517032e-05,5.99160588517e-05,3.85412722085e-05
Prevalence,United States,Male,20 to 24,Rheumatic heart disease,Percent,2017,4.48537895376e-05,5.58204345446e-05,3.52558920097e-05
Prevalence,United States,Female,20 to 24,Rheumatic heart disease,Percent,2017,4.52348248923e-05,5.63907583052e-05,3.60489453472e-05
Prevalence,United States,Male,25 to 29,Rheumatic heart disease,Percent,2017,4.0615607727e-05,5.13576602132e-05,3.25142075211e-05
Prevalence,United States,Female,25 to 29,Rheumatic heart disease,Percent,2017,4.03293526832e-05,5.01452452508e-05,3.27484856959e-05
Prevalence,United States,Male,30 to 34,Rheumatic heart disease,Percent,2017,3.70275199654e-05,4.867355562e-05,2.84982587567e-05
Prevalence,United States,Female,30 to 34,Rheumatic heart disease,Percent,2017,3.54004206229e-05,4.59618107072e-05,2.77288541866e-05
Prevalence,United States,Male,35 to 39,Rheumatic heart disease,Percent,2017,3.47883240956e-05,4.47199993598e-05,2.73967475444e-05
Prevalence,United States,Female,35 to 39,Rheumatic heart disease,Percent,2017,3.28558982877e-05,4.15880406364e-05,2.62641205347e-05
Prevalence,United States,Male,40 to 44,Rheumatic heart disease,Percent,2017,3.51119254021e-05,4.62186604852e-05,2.55044411035e-05
Prevalence,United States,Female,40 to 44,Rheumatic heart disease,Percent,2017,3.40731368876e-05,4.46536813638e-05,2.48743850018e-05
Prevalence,United States,Male,45 to 49,Rheumatic heart disease,Percent,2017,4.05052345013e-05,5.028185384e-05,3.1594399675e-05
Prevalence,United States,Female,45 to 49,Rheumatic heart disease,Percent,2017,4.20768940957e-05,5.16928795417e-05,3.29972770222e-05
Prevalence,United States,Male,50 to 54,Rheumatic heart disease,Percent,2017,5.0990582738e-05,6.35850441008e-05,3.89177698912e-05
Prevalence,United States,Female,50 to 54,Rheumatic heart disease,Percent,2017,5.46949071709e-05,6.87536468977e-05,4.13503720458e-05
Prevalence,United States,Male,55 to 59,Rheumatic heart disease,Percent,2017,7.32666906222e-05,8.82894096521e-05,6.03733405377e-05
Prevalence,United States,Female,55 to 59,Rheumatic heart disease,Percent,2017,7.38553174158e-05,8.83746332354e-05,6.1022830774e-05
Prevalence,United States,Male,60 to 64,Rheumatic heart disease,Percent,2017,0.000114490909475,0.00013923425295,9.43451542141e-05
Prevalence,United States,Female,60 to 64,Rheumatic heart disease,Percent,2017,0.00010816848064,0.000130996712945,8.82973716847e-05
Prevalence,United States,Male,65 to 69,Rheumatic heart disease,Percent,2017,0.000210753282854,0.000250731286223,0.000173470597098
Prevalence,United States,Female,65 to 69,Rheumatic heart disease,Percent,2017,0.000189589801996,0.000222607551277,0.000157274887327
Prevalence,United States,Male,70 to 74,Rheumatic heart disease,Percent,2017,0.000351959721813,0.000424485663885,0.000290869825008
Prevalence,United States,Female,70 to 74,Rheumatic heart disease,Percent,2017,0.00030305345528,0.000362393979796,0.00024934122889
Prevalence,United States,Male,75 to 79,Rheumatic heart disease,Percent,2017,0.000510214138952,0.000610069603139,0.000420922445551
Prevalence,United States,Female,75 to 79,Rheumatic heart disease,Percent,2017,0.000432305004085,0.000507430344076,0.000361295183547
Prevalence,United States,Male,80 plus,Rheumatic heart disease,Percent,2017,0.00075533846641,0.000882762709634,0.000639882749942
Prevalence,United States,Female,80 plus,Rheumatic heart disease,Percent,2017,0.000585326025211,0.000680804836426,0.00050119641537
Prevalence,United States,Male,10 to 14,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Female,10 to 14,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,United States,Male,15 to 19,Ischemic heart disease,Percent,2017,0.000146754057364,0.000177529383297,0.000118985286676
Prevalence,United States,Female,15 to 19,Ischemic heart disease,Percent,2017,0.000116808326872,0.000140880114803,9.50876189803e-05
Prevalence,United States,Male,20 to 24,Ischemic heart disease,Percent,2017,0.00041222897283,0.000472383885991,0.000357863820078
Prevalence,United States,Female,20 to 24,Ischemic heart disease,Percent,2017,0.000332299513565,0.000381898556494,0.000285960586556
Prevalence,United States,Male,25 to 29,Ischemic heart disease,Percent,2017,0.000915125763883,0.00104917894941,0.000796238661232
Prevalence,United States,Female,25 to 29,Ischemic heart disease,Percent,2017,0.000662431118041,0.000743947517928,0.000590144657289
Prevalence,United States,Male,30 to 34,Ischemic heart disease,Percent,2017,0.0021588817507,0.00247034552987,0.00188324717236
Prevalence,United States,Female,30 to 34,Ischemic heart disease,Percent,2017,0.00133551595333,0.00152081431015,0.00118762227655
Prevalence,United States,Male,35 to 39,Ischemic heart disease,Percent,2017,0.00525523887197,0.00611394500739,0.00453861293215
Prevalence,United States,Female,35 to 39,Ischemic heart disease,Percent,2017,0.00279646067737,0.00320467716289,0.00247516425428
Prevalence,United States,Male,40 to 44,Ischemic heart disease,Percent,2017,0.0112452023601,0.0130232353473,0.00970496482773
Prevalence,United States,Female,40 to 44,Ischemic heart disease,Percent,2017,0.00558028567677,0.00640822618777,0.0049203184582
Prevalence,United States,Male,45 to 49,Ischemic heart disease,Percent,2017,0.0209595899851,0.0241405765796,0.0183943482746
Prevalence,United States,Female,45 to 49,Ischemic heart disease,Percent,2017,0.0100364169621,0.0114270451873,0.00892370323247
Prevalence,United States,Male,50 to 54,Ischemic heart disease,Percent,2017,0.0358134652325,0.0425710708815,0.0308410657216
Prevalence,United States,Female,50 to 54,Ischemic heart disease,Percent,2017,0.0167371533888,0.0194447698732,0.014648205312
Prevalence,United States,Male,55 to 59,Ischemic heart disease,Percent,2017,0.0561468287411,0.0648500867395,0.0485107183868
Prevalence,United States,Female,55 to 59,Ischemic heart disease,Percent,2017,0.0256977345557,0.0294782766802,0.0223769835868
Prevalence,United States,Male,60 to 64,Ischemic heart disease,Percent,2017,0.0823645251565,0.0947929723381,0.0706892639815
Prevalence,United States,Female,60 to 64,Ischemic heart disease,Percent,2017,0.0376674542143,0.0433209220127,0.0327227160615
Prevalence,United States,Male,65 to 69,Ischemic heart disease,Percent,2017,0.123077801431,0.140285238809,0.106863593562
Prevalence,United States,Female,65 to 69,Ischemic heart disease,Percent,2017,0.0586492906214,0.0670956057851,0.0509370355154
Prevalence,United States,Male,70 to 74,Ischemic heart disease,Percent,2017,0.1600721353,0.18365581256,0.138253674583
Prevalence,United States,Female,70 to 74,Ischemic heart disease,Percent,2017,0.0812948246503,0.0941100584794,0.0694967677658
Prevalence,United States,Male,75 to 79,Ischemic heart disease,Percent,2017,0.199290997802,0.226342349099,0.172134745876
Prevalence,United States,Female,75 to 79,Ischemic heart disease,Percent,2017,0.107999772917,0.123867163227,0.0918069552677
Prevalence,United States,Male,80 plus,Ischemic heart disease,Percent,2017,0.224396098042,0.259862319385,0.191844776222
Prevalence,United States,Female,80 plus,Ischemic heart disease,Percent,2017,0.133116097369,0.155622911947,0.112848623579
Prevalence,Global,Male,10 to 14,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,10 to 14,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,15 to 19,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,15 to 19,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,20 to 24,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,20 to 24,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,25 to 29,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,25 to 29,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,30 to 34,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,30 to 34,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,35 to 39,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,35 to 39,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,40 to 44,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,40 to 44,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,45 to 49,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,45 to 49,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,50 to 54,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,50 to 54,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,55 to 59,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,55 to 59,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,60 to 64,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,60 to 64,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,65 to 69,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,65 to 69,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,70 to 74,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,70 to 74,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,75 to 79,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,75 to 79,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,80 plus,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Female,80 plus,All causes,Percent,2017,1.0,1.0,1.0
Prevalence,Global,Male,10 to 14,Lower respiratory infections,Percent,2017,0.00204619885845,0.00264545832227,0.00152052377666
Prevalence,Global,Female,10 to 14,Lower respiratory infections,Percent,2017,0.00187346922439,0.0024024827705,0.00139410932963
Prevalence,Global,Male,15 to 19,Lower respiratory infections,Percent,2017,0.00176815078516,0.00208111459043,0.00148748558904
Prevalence,Global,Female,15 to 19,Lower respiratory infections,Percent,2017,0.00171248660048,0.00200496260396,0.00145092345727
Prevalence,Global,Male,20 to 24,Lower respiratory infections,Percent,2017,0.00149052406467,0.00182971948734,0.00118295897041
Prevalence,Global,Female,20 to 24,Lower respiratory infections,Percent,2017,0.00149060806989,0.00182090240613,0.00118724456574
Prevalence,Global,Male,25 to 29,Lower respiratory infections,Percent,2017,0.00124168171339,0.00145235187078,0.00103659952485
Prevalence,Global,Female,25 to 29,Lower respiratory infections,Percent,2017,0.00120356028196,0.00141397291328,0.00100595915085
Prevalence,Global,Male,30 to 34,Lower respiratory infections,Percent,2017,0.00108464213987,0.00122831947677,0.000952061252194
Prevalence,Global,Female,30 to 34,Lower respiratory infections,Percent,2017,0.00101489719892,0.00114574116239,0.000890761359404
Prevalence,Global,Male,35 to 39,Lower respiratory infections,Percent,2017,0.000955697557724,0.00110520126464,0.000813630658855
Prevalence,Global,Female,35 to 39,Lower respiratory infections,Percent,2017,0.000851669399994,0.0009835617523,0.000725973420059
Prevalence,Global,Male,40 to 44,Lower respiratory infections,Percent,2017,0.00084463593618,0.000998371476819,0.000711213674667
Prevalence,Global,Female,40 to 44,Lower respiratory infections,Percent,2017,0.0007184692189,0.000853252808893,0.000596620224762
Prevalence,Global,Male,45 to 49,Lower respiratory infections,Percent,2017,0.00081613630732,0.000929096598522,0.000717642212684
Prevalence,Global,Female,45 to 49,Lower respiratory infections,Percent,2017,0.000683329650141,0.000781046172103,0.000599278433155
Prevalence,Global,Male,50 to 54,Lower respiratory infections,Percent,2017,0.000812117911429,0.00091751034835,0.000715288704148
Prevalence,Global,Female,50 to 54,Lower respiratory infections,Percent,2017,0.000666571014924,0.000752158312427,0.000588063413832
Prevalence,Global,Male,55 to 59,Lower respiratory infections,Percent,2017,0.000883660778445,0.00101987232134,0.000748936775344
Prevalence,Global,Female,55 to 59,Lower respiratory infections,Percent,2017,0.000705766771276,0.000814863540191,0.0005964762192
Prevalence,Global,Male,60 to 64,Lower respiratory infections,Percent,2017,0.000918087016313,0.00105058715722,0.000786558661769
Prevalence,Global,Female,60 to 64,Lower respiratory infections,Percent,2017,0.000730724454271,0.000844085642483,0.000623393660477
Prevalence,Global,Male,65 to 69,Lower respiratory infections,Percent,2017,0.00107151547549,0.00118956938338,0.000963744793337
Prevalence,Global,Female,65 to 69,Lower respiratory infections,Percent,2017,0.00084225347658,0.000937065422671,0.000757307055275
Prevalence,Global,Male,70 to 74,Lower respiratory infections,Percent,2017,0.00120572010823,0.00135844605036,0.00106555231684
Prevalence,Global,Female,70 to 74,Lower respiratory infections,Percent,2017,0.000954855378707,0.00107696619065,0.000846796015145
Prevalence,Global,Male,75 to 79,Lower respiratory infections,Percent,2017,0.00135524726333,0.00155115108248,0.0011669146086
Prevalence,Global,Female,75 to 79,Lower respiratory infections,Percent,2017,0.00105478633095,0.00121100883726,0.000909292496838
Prevalence,Global,Male,80 plus,Lower respiratory infections,Percent,2017,0.00260570194079,0.00287753423936,0.00237145038189
Prevalence,Global,Female,80 plus,Lower respiratory infections,Percent,2017,0.00194794996155,0.002142219098,0.00177302891504
Prevalence,Global,Male,10 to 14,Upper respiratory infections,Percent,2017,0.0349133459367,0.0470817519442,0.0232294789319
Prevalence,Global,Female,10 to 14,Upper respiratory infections,Percent,2017,0.0344838909232,0.0463749147392,0.0229001100097
Prevalence,Global,Male,15 to 19,Upper respiratory infections,Percent,2017,0.0323921171274,0.0446852433858,0.0224599643229
Prevalence,Global,Female,15 to 19,Upper respiratory infections,Percent,2017,0.0324897974439,0.0446150257406,0.0224845715277
Prevalence,Global,Male,20 to 24,Upper respiratory infections,Percent,2017,0.0319960596129,0.0434174120146,0.0222114804694
Prevalence,Global,Female,20 to 24,Upper respiratory infections,Percent,2017,0.0323459773201,0.0439160048677,0.0224298421779
Prevalence,Global,Male,25 to 29,Upper respiratory infections,Percent,2017,0.0319471018438,0.0437464314352,0.0223291114068
Prevalence,Global,Female,25 to 29,Upper respiratory infections,Percent,2017,0.0324113289939,0.0443123072071,0.0226340953517
Prevalence,Global,Male,30 to 34,Upper respiratory infections,Percent,2017,0.0310512035874,0.0418119356894,0.0218327405204
Prevalence,Global,Female,30 to 34,Upper respiratory infections,Percent,2017,0.0317436840724,0.0426073864581,0.0223290066138
Prevalence,Global,Male,35 to 39,Upper respiratory infections,Percent,2017,0.030927670584,0.0426804416323,0.0221476728912
Prevalence,Global,Female,35 to 39,Upper respiratory infections,Percent,2017,0.0317367796236,0.0437142928638,0.0226615631386
Prevalence,Global,Male,40 to 44,Upper respiratory infections,Percent,2017,0.029728542887,0.0412686192427,0.0203012569137
Prevalence,Global,Female,40 to 44,Upper respiratory infections,Percent,2017,0.0302639289655,0.042180291282,0.0205937278355
Prevalence,Global,Male,45 to 49,Upper respiratory infections,Percent,2017,0.0278000989609,0.0403487525833,0.019092474663
Prevalence,Global,Female,45 to 49,Upper respiratory infections,Percent,2017,0.0282279759209,0.0408950916712,0.0193872990242
Prevalence,Global,Male,50 to 54,Upper respiratory infections,Percent,2017,0.0265809425593,0.0364582685348,0.0185682214154
Prevalence,Global,Female,50 to 54,Upper respiratory infections,Percent,2017,0.0269587297499,0.036851483339,0.0187885826519
Prevalence,Global,Male,55 to 59,Upper respiratory infections,Percent,2017,0.0257944327579,0.0358669545682,0.0178781004533
Prevalence,Global,Female,55 to 59,Upper respiratory infections,Percent,2017,0.0259995752191,0.0360733477173,0.017986210705
Prevalence,Global,Male,60 to 64,Upper respiratory infections,Percent,2017,0.0239071365615,0.0324836088575,0.0160343487996
Prevalence,Global,Female,60 to 64,Upper respiratory infections,Percent,2017,0.0238641260625,0.0324216951159,0.0159357580537
Prevalence,Global,Male,65 to 69,Upper respiratory infections,Percent,2017,0.0231950562568,0.0325715432546,0.0161114856414
Prevalence,Global,Female,65 to 69,Upper respiratory infections,Percent,2017,0.0229278528292,0.0322911121242,0.0158983565717
Prevalence,Global,Male,70 to 74,Upper respiratory infections,Percent,2017,0.0220341328773,0.0310240819473,0.0153730673813
Prevalence,Global,Female,70 to 74,Upper respiratory infections,Percent,2017,0.021777764644,0.0308244922063,0.0152409049116
Prevalence,Global,Male,75 to 79,Upper respiratory infections,Percent,2017,0.020290745919,0.0290301536652,0.0136289727416
Prevalence,Global,Female,75 to 79,Upper respiratory infections,Percent,2017,0.0201199365329,0.0288325763132,0.0136565881967
Prevalence,Global,Male,80 plus,Upper respiratory infections,Percent,2017,0.0200736865973,0.026007716514,0.0155420124491
Prevalence,Global,Female,80 plus,Upper respiratory infections,Percent,2017,0.0195871191975,0.0252123196809,0.0152713188378
Prevalence,Global,Male,20 to 24,Hypertensive heart disease,Percent,2017,6.32327299308e-05,8.96132899545e-05,4.34036738388e-05
Prevalence,Global,Female,20 to 24,Hypertensive heart disease,Percent,2017,9.45120309986e-05,0.000131549277192,6.68582957843e-05
Prevalence,Global,Male,25 to 29,Hypertensive heart disease,Percent,2017,0.000197562153293,0.00028004947816,0.000133739405761
Prevalence,Global,Female,25 to 29,Hypertensive heart disease,Percent,2017,0.000294701599051,0.00041285465433,0.000204669176961
Prevalence,Global,Male,30 to 34,Hypertensive heart disease,Percent,2017,0.000351748684541,0.000470401924518,0.000250870026835
Prevalence,Global,Female,30 to 34,Hypertensive heart disease,Percent,2017,0.000492954884163,0.000649520916274,0.000353682653166
Prevalence,Global,Male,35 to 39,Hypertensive heart disease,Percent,2017,0.000429953876112,0.000591122386699,0.00029131252296
Prevalence,Global,Female,35 to 39,Hypertensive heart disease,Percent,2017,0.000546040482755,0.000735517488237,0.000377908051984
Prevalence,Global,Male,40 to 44,Hypertensive heart disease,Percent,2017,0.000631291693124,0.000841862251085,0.000452531314154
Prevalence,Global,Female,40 to 44,Hypertensive heart disease,Percent,2017,0.000777861395267,0.00103123354556,0.000560984503805
Prevalence,Global,Male,45 to 49,Hypertensive heart disease,Percent,2017,0.00134261052666,0.00173741657897,0.0010278637212
Prevalence,Global,Female,45 to 49,Hypertensive heart disease,Percent,2017,0.00177347411381,0.00224586775348,0.00138660630423
Prevalence,Global,Male,50 to 54,Hypertensive heart disease,Percent,2017,0.00216486449351,0.00279588354312,0.0016139772047
Prevalence,Global,Female,50 to 54,Hypertensive heart disease,Percent,2017,0.00295814060642,0.00372365589228,0.00227401582942
Prevalence,Global,Male,55 to 59,Hypertensive heart disease,Percent,2017,0.00288306696719,0.00380037910675,0.00209602870602
Prevalence,Global,Female,55 to 59,Hypertensive heart disease,Percent,2017,0.00390407659363,0.00503754620664,0.00289952385062
Prevalence,Global,Male,60 to 64,Hypertensive heart disease,Percent,2017,0.00457043034879,0.00601878402005,0.00333566048009
Prevalence,Global,Female,60 to 64,Hypertensive heart disease,Percent,2017,0.00634102814006,0.00818265975613,0.0047635201611
Prevalence,Global,Male,65 to 69,Hypertensive heart disease,Percent,2017,0.00761956062656,0.00988029299447,0.00568082703805
Prevalence,Global,Female,65 to 69,Hypertensive heart disease,Percent,2017,0.0113654998595,0.0143936702477,0.00876515782372
Prevalence,Global,Male,70 to 74,Hypertensive heart disease,Percent,2017,0.0108870821644,0.0146178264426,0.00780486640907
Prevalence,Global,Female,70 to 74,Hypertensive heart disease,Percent,2017,0.0169422573781,0.0220755137322,0.012534874748
Prevalence,Global,Male,75 to 79,Hypertensive heart disease,Percent,2017,0.0145557672454,0.0196402066971,0.0105543468721
Prevalence,Global,Female,75 to 79,Hypertensive heart disease,Percent,2017,0.0226425542795,0.0298995501884,0.0166420610864
Prevalence,Global,Male,80 plus,Hypertensive heart disease,Percent,2017,0.0227186987657,0.0290057993651,0.0175999206146
Prevalence,Global,Female,80 plus,Hypertensive heart disease,Percent,2017,0.0360659966461,0.0453617478102,0.0288290758344
Prevalence,Global,Male,10 to 14,Chronic obstructive pulmonary disease,Percent,2017,0.00197516102968,0.00240086720717,0.00145647615292
Prevalence,Global,Female,10 to 14,Chronic obstructive pulmonary disease,Percent,2017,0.00249992772376,0.00280154562203,0.0020771970646
Prevalence,Global,Male,15 to 19,Chronic obstructive pulmonary disease,Percent,2017,0.00356421547058,0.00440469814862,0.0027815181095
Prevalence,Global,Female,15 to 19,Chronic obstructive pulmonary disease,Percent,2017,0.00511903943884,0.0061367664257,0.00417468020556
Prevalence,Global,Male,20 to 24,Chronic obstructive pulmonary disease,Percent,2017,0.00604784675225,0.00757838359176,0.00456640051455
Prevalence,Global,Female,20 to 24,Chronic obstructive pulmonary disease,Percent,2017,0.00934247109029,0.0116631956111,0.00718106138804
Prevalence,Global,Male,25 to 29,Chronic obstructive pulmonary disease,Percent,2017,0.0090633610068,0.0111606556977,0.0071541266373
Prevalence,Global,Female,25 to 29,Chronic obstructive pulmonary disease,Percent,2017,0.0141419252309,0.017475884391,0.0113132567396
Prevalence,Global,Male,30 to 34,Chronic obstructive pulmonary disease,Percent,2017,0.0128639311607,0.0158601509526,0.0103104407473
Prevalence,Global,Female,30 to 34,Chronic obstructive pulmonary disease,Percent,2017,0.0188580495975,0.0231132814334,0.0153218090642
Prevalence,Global,Male,35 to 39,Chronic obstructive pulmonary disease,Percent,2017,0.0184859879833,0.022126837115,0.0153227039804
Prevalence,Global,Female,35 to 39,Chronic obstructive pulmonary disease,Percent,2017,0.024911460753,0.0297995297565,0.0209989156606
Prevalence,Global,Male,40 to 44,Chronic obstructive pulmonary disease,Percent,2017,0.0273167483497,0.0327963172808,0.0226222969078
Prevalence,Global,Female,40 to 44,Chronic obstructive pulmonary disease,Percent,2017,0.0343954250981,0.0408874899258,0.0285893690332
Prevalence,Global,Male,45 to 49,Chronic obstructive pulmonary disease,Percent,2017,0.0406963162249,0.0488442739744,0.0342416875795
Prevalence,Global,Female,45 to 49,Chronic obstructive pulmonary disease,Percent,2017,0.046954717596,0.055281093951,0.0397006519484
Prevalence,Global,Male,50 to 54,Chronic obstructive pulmonary disease,Percent,2017,0.0604198282884,0.071632141075,0.0509742725499
Prevalence,Global,Female,50 to 54,Chronic obstructive pulmonary disease,Percent,2017,0.063216696807,0.0747079219126,0.053864861298
Prevalence,Global,Male,55 to 59,Chronic obstructive pulmonary disease,Percent,2017,0.0881263931337,0.103027783178,0.0744235923965
Prevalence,Global,Female,55 to 59,Chronic obstructive pulmonary disease,Percent,2017,0.0853065856465,0.0997764309083,0.0721583325156
Prevalence,Global,Male,60 to 64,Chronic obstructive pulmonary disease,Percent,2017,0.120825563781,0.141599169303,0.102154566081
Prevalence,Global,Female,60 to 64,Chronic obstructive pulmonary disease,Percent,2017,0.112627589621,0.132714527371,0.0946759744419
Prevalence,Global,Male,65 to 69,Chronic obstructive pulmonary disease,Percent,2017,0.160272332616,0.186098502745,0.13426226002
Prevalence,Global,Female,65 to 69,Chronic obstructive pulmonary disease,Percent,2017,0.147618979033,0.171672325287,0.123567583388
Prevalence,Global,Male,70 to 74,Chronic obstructive pulmonary disease,Percent,2017,0.20316085004,0.235671486974,0.173583090549
Prevalence,Global,Female,70 to 74,Chronic obstructive pulmonary disease,Percent,2017,0.18545914561,0.21540641923,0.15810527749
Prevalence,Global,Male,75 to 79,Chronic obstructive pulmonary disease,Percent,2017,0.239063119578,0.279757894034,0.205640774001
Prevalence,Global,Female,75 to 79,Chronic obstructive pulmonary disease,Percent,2017,0.21977570931,0.257526235404,0.188983949998
Prevalence,Global,Male,80 plus,Chronic obstructive pulmonary disease,Percent,2017,0.280025054432,0.324403070462,0.245367670789
Prevalence,Global,Female,80 plus,Chronic obstructive pulmonary disease,Percent,2017,0.258590777286,0.298790202395,0.225344248793
Prevalence,Global,Male,10 to 14,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,10 to 14,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,15 to 19,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,15 to 19,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,20 to 24,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,20 to 24,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,25 to 29,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,25 to 29,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,30 to 34,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,30 to 34,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,35 to 39,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,35 to 39,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,40 to 44,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,40 to 44,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,45 to 49,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,45 to 49,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,50 to 54,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,50 to 54,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,55 to 59,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,55 to 59,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,60 to 64,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,60 to 64,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,65 to 69,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,65 to 69,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,70 to 74,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,70 to 74,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,75 to 79,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,75 to 79,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,80 plus,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,80 plus,Other chronic respiratory diseases,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,10 to 14,Injuries,Percent,2017,0.0621560239443,0.0695523079074,0.0564269201393
Prevalence,Global,Female,10 to 14,Injuries,Percent,2017,0.0683745693394,0.0778790585649,0.0600760443184
Prevalence,Global,Male,15 to 19,Injuries,Percent,2017,0.0958558441073,0.106848278694,0.0868523548669
Prevalence,Global,Female,15 to 19,Injuries,Percent,2017,0.112381317378,0.133449990231,0.0941887884738
Prevalence,Global,Male,20 to 24,Injuries,Percent,2017,0.135291654448,0.149544764495,0.123654935529
Prevalence,Global,Female,20 to 24,Injuries,Percent,2017,0.151371255575,0.177811641983,0.128521988162
Prevalence,Global,Male,25 to 29,Injuries,Percent,2017,0.172024687265,0.187031183854,0.158471825158
Prevalence,Global,Female,25 to 29,Injuries,Percent,2017,0.178570076754,0.207130045856,0.155743514353
Prevalence,Global,Male,30 to 34,Injuries,Percent,2017,0.217136241449,0.234855829072,0.202392558722
Prevalence,Global,Female,30 to 34,Injuries,Percent,2017,0.202202411138,0.233116181177,0.179542734853
Prevalence,Global,Male,35 to 39,Injuries,Percent,2017,0.255633326927,0.273834705204,0.240003962767
Prevalence,Global,Female,35 to 39,Injuries,Percent,2017,0.214394195345,0.239049268195,0.190454669033
Prevalence,Global,Male,40 to 44,Injuries,Percent,2017,0.287109392743,0.308743860391,0.269791022138
Prevalence,Global,Female,40 to 44,Injuries,Percent,2017,0.232493500069,0.260488355502,0.209010740368
Prevalence,Global,Male,45 to 49,Injuries,Percent,2017,0.320210562807,0.343597468629,0.301940768671
Prevalence,Global,Female,45 to 49,Injuries,Percent,2017,0.249774331315,0.2815908789,0.226216460412
Prevalence,Global,Male,50 to 54,Injuries,Percent,2017,0.354745765384,0.37838045748,0.336174067607
Prevalence,Global,Female,50 to 54,Injuries,Percent,2017,0.264309162157,0.290417788775,0.242800551296
Prevalence,Global,Male,55 to 59,Injuries,Percent,2017,0.400465713297,0.426392446634,0.3810045515
Prevalence,Global,Female,55 to 59,Injuries,Percent,2017,0.287121165122,0.308880903499,0.267823036914
Prevalence,Global,Male,60 to 64,Injuries,Percent,2017,0.428636721588,0.453564467367,0.408254343667
Prevalence,Global,Female,60 to 64,Injuries,Percent,2017,0.319443714477,0.343141320794,0.301460085456
Prevalence,Global,Male,65 to 69,Injuries,Percent,2017,0.461244057344,0.487514802473,0.440170073849
Prevalence,Global,Female,65 to 69,Injuries,Percent,2017,0.361806895194,0.388124951166,0.34002057684
Prevalence,Global,Male,70 to 74,Injuries,Percent,2017,0.486212072744,0.516578300313,0.463044443097
Prevalence,Global,Female,70 to 74,Injuries,Percent,2017,0.397992528021,0.431771167709,0.372777538107
Prevalence,Global,Male,75 to 79,Injuries,Percent,2017,0.533670698181,0.563917166241,0.507903149957
Prevalence,Global,Female,75 to 79,Injuries,Percent,2017,0.466843888268,0.504053553751,0.436519144033
Prevalence,Global,Male,80 plus,Injuries,Percent,2017,0.628773690207,0.66207168998,0.602820417993
Prevalence,Global,Female,80 plus,Injuries,Percent,2017,0.602815401824,0.64140161207,0.573127988413
Prevalence,Global,Male,10 to 14,Other malignant neoplasms,Percent,2017,0.000444110105991,0.000733954167126,0.00031055289393
Prevalence,Global,Female,10 to 14,Other malignant neoplasms,Percent,2017,0.000631546403819,0.00109572910523,0.000405534655421
Prevalence,Global,Male,15 to 19,Other malignant neoplasms,Percent,2017,0.000331627471467,0.000522088065228,0.00023890166477
Prevalence,Global,Female,15 to 19,Other malignant neoplasms,Percent,2017,0.000320331046269,0.000489536511033,0.000225478597306
Prevalence,Global,Male,20 to 24,Other malignant neoplasms,Percent,2017,0.000318890389974,0.000469712687804,0.000232779431817
Prevalence,Global,Female,20 to 24,Other malignant neoplasms,Percent,2017,0.000353400448846,0.000577343863327,0.000237956400873
Prevalence,Global,Male,25 to 29,Other malignant neoplasms,Percent,2017,0.000778482430965,0.00129403261944,0.000525098298934
Prevalence,Global,Female,25 to 29,Other malignant neoplasms,Percent,2017,0.000885137382845,0.00138539415093,0.000571378679282
Prevalence,Global,Male,30 to 34,Other malignant neoplasms,Percent,2017,0.00125912476817,0.00207000724123,0.000814905946271
Prevalence,Global,Female,30 to 34,Other malignant neoplasms,Percent,2017,0.00121515698981,0.0019851914573,0.000791763886753
Prevalence,Global,Male,35 to 39,Other malignant neoplasms,Percent,2017,0.000888828851846,0.00138451451847,0.000621073668634
Prevalence,Global,Female,35 to 39,Other malignant neoplasms,Percent,2017,0.000663658501971,0.000987919475237,0.000470065641338
Prevalence,Global,Male,40 to 44,Other malignant neoplasms,Percent,2017,0.00112212900217,0.00173275750656,0.000754298070227
Prevalence,Global,Female,40 to 44,Other malignant neoplasms,Percent,2017,0.000647674125686,0.000894745636153,0.00048994751349
Prevalence,Global,Male,45 to 49,Other malignant neoplasms,Percent,2017,0.00120428751613,0.00174902965472,0.00088357419152
Prevalence,Global,Female,45 to 49,Other malignant neoplasms,Percent,2017,0.0010156177926,0.00154810614705,0.000736452095862
Prevalence,Global,Male,50 to 54,Other malignant neoplasms,Percent,2017,0.00126090670663,0.00180220350774,0.00095343132824
Prevalence,Global,Female,50 to 54,Other malignant neoplasms,Percent,2017,0.000940806213108,0.00135111358974,0.00070147663456
Prevalence,Global,Male,55 to 59,Other malignant neoplasms,Percent,2017,0.00146499658162,0.00195687050441,0.00115358079895
Prevalence,Global,Female,55 to 59,Other malignant neoplasms,Percent,2017,0.000830722472902,0.00103842560785,0.000672637549923
Prevalence,Global,Male,60 to 64,Other malignant neoplasms,Percent,2017,0.00268729117666,0.00385327826619,0.00197506137039
Prevalence,Global,Female,60 to 64,Other malignant neoplasms,Percent,2017,0.00136480532128,0.00175396245733,0.00108339620588
Prevalence,Global,Male,65 to 69,Other malignant neoplasms,Percent,2017,0.0032976045577,0.00461440755853,0.00234092670791
Prevalence,Global,Female,65 to 69,Other malignant neoplasms,Percent,2017,0.00157846388876,0.00207059694255,0.00124462476643
Prevalence,Global,Male,70 to 74,Other malignant neoplasms,Percent,2017,0.00403894760541,0.00621997981492,0.00292494533671
Prevalence,Global,Female,70 to 74,Other malignant neoplasms,Percent,2017,0.00179986076895,0.00238283860408,0.00142700450599
Prevalence,Global,Male,75 to 79,Other malignant neoplasms,Percent,2017,0.00478828251831,0.00792592334873,0.00332790224339
Prevalence,Global,Female,75 to 79,Other malignant neoplasms,Percent,2017,0.00200115054048,0.00262750159929,0.00154723724926
Prevalence,Global,Male,80 plus,Other malignant neoplasms,Percent,2017,0.0057430304971,0.0105604841382,0.0038280401311
Prevalence,Global,Female,80 plus,Other malignant neoplasms,Percent,2017,0.00220540524395,0.00305526491134,0.00166227486173
Prevalence,Global,Male,10 to 14,Rheumatic heart disease,Percent,2017,0.00374413029733,0.00394808481734,0.00353391034858
Prevalence,Global,Female,10 to 14,Rheumatic heart disease,Percent,2017,0.0047252202681,0.00495276238734,0.00447940109312
Prevalence,Global,Male,15 to 19,Rheumatic heart disease,Percent,2017,0.00501490201959,0.00522478182415,0.00479317570468
Prevalence,Global,Female,15 to 19,Rheumatic heart disease,Percent,2017,0.00629023847595,0.00656457410725,0.00602316059607
Prevalence,Global,Male,20 to 24,Rheumatic heart disease,Percent,2017,0.00596280153164,0.00620987109944,0.00571885080687
Prevalence,Global,Female,20 to 24,Rheumatic heart disease,Percent,2017,0.0074699454461,0.00777143403215,0.00718254452353
Prevalence,Global,Male,25 to 29,Rheumatic heart disease,Percent,2017,0.00655991937778,0.00682963154836,0.00629242758943
Prevalence,Global,Female,25 to 29,Rheumatic heart disease,Percent,2017,0.00823451253776,0.00856257433124,0.00792380212602
Prevalence,Global,Male,30 to 34,Rheumatic heart disease,Percent,2017,0.00693950427257,0.00722294211954,0.0066649035897
Prevalence,Global,Female,30 to 34,Rheumatic heart disease,Percent,2017,0.0086350494882,0.00896615099864,0.00831837641227
Prevalence,Global,Male,35 to 39,Rheumatic heart disease,Percent,2017,0.00702348079946,0.00730240986292,0.00675311081326
Prevalence,Global,Female,35 to 39,Rheumatic heart disease,Percent,2017,0.00866455847746,0.00899130411038,0.00834559580379
Prevalence,Global,Male,40 to 44,Rheumatic heart disease,Percent,2017,0.00695512825559,0.00723721192188,0.00669791771531
Prevalence,Global,Female,40 to 44,Rheumatic heart disease,Percent,2017,0.0085312564173,0.00885049919886,0.00822887562694
Prevalence,Global,Male,45 to 49,Rheumatic heart disease,Percent,2017,0.00649257740002,0.00675258208355,0.00625244866249
Prevalence,Global,Female,45 to 49,Rheumatic heart disease,Percent,2017,0.00799756203945,0.00829549550408,0.00770786352502
Prevalence,Global,Male,50 to 54,Rheumatic heart disease,Percent,2017,0.00572776807241,0.00595876222722,0.00551370122819
Prevalence,Global,Female,50 to 54,Rheumatic heart disease,Percent,2017,0.00722642451191,0.00750654632029,0.0069683099193
Prevalence,Global,Male,55 to 59,Rheumatic heart disease,Percent,2017,0.00460215336699,0.00478548195189,0.00442252377285
Prevalence,Global,Female,55 to 59,Rheumatic heart disease,Percent,2017,0.00596602453423,0.006191159098,0.00575203051893
Prevalence,Global,Male,60 to 64,Rheumatic heart disease,Percent,2017,0.00382561965589,0.00399387111058,0.00365920210473
Prevalence,Global,Female,60 to 64,Rheumatic heart disease,Percent,2017,0.0051224537163,0.00532204141832,0.00492005134498
Prevalence,Global,Male,65 to 69,Rheumatic heart disease,Percent,2017,0.00295606533696,0.00309288612538,0.00282823177689
Prevalence,Global,Female,65 to 69,Rheumatic heart disease,Percent,2017,0.00407418672565,0.00424088848281,0.00390953068553
Prevalence,Global,Male,70 to 74,Rheumatic heart disease,Percent,2017,0.00232370076243,0.00243551192332,0.00220673994415
Prevalence,Global,Female,70 to 74,Rheumatic heart disease,Percent,2017,0.00326640099545,0.00341354706648,0.00311198018678
Prevalence,Global,Male,75 to 79,Rheumatic heart disease,Percent,2017,0.00179146417917,0.00188561787801,0.00169339993488
Prevalence,Global,Female,75 to 79,Rheumatic heart disease,Percent,2017,0.00250927885031,0.00262911134699,0.00238741759402
Prevalence,Global,Male,80 plus,Rheumatic heart disease,Percent,2017,0.00120151340387,0.00127148387218,0.00113456186539
Prevalence,Global,Female,80 plus,Rheumatic heart disease,Percent,2017,0.00158888297789,0.00167585296738,0.00150804331478
Prevalence,Global,Male,10 to 14,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,10 to 14,Ischemic heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,15 to 19,Ischemic heart disease,Percent,2017,0.000140107070444,0.000170304403009,0.000111737867352
Prevalence,Global,Female,15 to 19,Ischemic heart disease,Percent,2017,0.000153318695093,0.000182549422546,0.000125724416148
Prevalence,Global,Male,20 to 24,Ischemic heart disease,Percent,2017,0.0005201950607,0.000591889247128,0.000452896694693
Prevalence,Global,Female,20 to 24,Ischemic heart disease,Percent,2017,0.000506636385503,0.00057528157997,0.000438848100311
Prevalence,Global,Male,25 to 29,Ischemic heart disease,Percent,2017,0.00123528067748,0.00134852343749,0.00112966159387
Prevalence,Global,Female,25 to 29,Ischemic heart disease,Percent,2017,0.00103383929495,0.00112891641735,0.000940202527129
Prevalence,Global,Male,30 to 34,Ischemic heart disease,Percent,2017,0.00260783825167,0.00285527117265,0.00237103461928
Prevalence,Global,Female,30 to 34,Ischemic heart disease,Percent,2017,0.00200677441718,0.00220123689857,0.00181346885213
Prevalence,Global,Male,35 to 39,Ischemic heart disease,Percent,2017,0.00571837473721,0.00624444042412,0.00520217524922
Prevalence,Global,Female,35 to 39,Ischemic heart disease,Percent,2017,0.00403161414718,0.00444030351327,0.00362986539718
Prevalence,Global,Male,40 to 44,Ischemic heart disease,Percent,2017,0.0117059225768,0.0127788339466,0.0106488089325
Prevalence,Global,Female,40 to 44,Ischemic heart disease,Percent,2017,0.00817665657072,0.00897698076833,0.00736432649716
Prevalence,Global,Male,45 to 49,Ischemic heart disease,Percent,2017,0.0189059053454,0.0206213815007,0.0174115501065
Prevalence,Global,Female,45 to 49,Ischemic heart disease,Percent,2017,0.0135282010332,0.0148127378054,0.0123474210346
Prevalence,Global,Male,50 to 54,Ischemic heart disease,Percent,2017,0.0281928303274,0.0312097123259,0.0255901071546
Prevalence,Global,Female,50 to 54,Ischemic heart disease,Percent,2017,0.0202369349143,0.0225088224218,0.0182602206824
Prevalence,Global,Male,55 to 59,Ischemic heart disease,Percent,2017,0.0424827709358,0.0467240975578,0.0387990278032
Prevalence,Global,Female,55 to 59,Ischemic heart disease,Percent,2017,0.0296936172883,0.0327565548502,0.0270531365555
Prevalence,Global,Male,60 to 64,Ischemic heart disease,Percent,2017,0.0588576263841,0.0647363092183,0.0531004412706
Prevalence,Global,Female,60 to 64,Ischemic heart disease,Percent,2017,0.042511831581,0.0470262661166,0.0385512024904
Prevalence,Global,Male,65 to 69,Ischemic heart disease,Percent,2017,0.0868418236091,0.0955829731091,0.0790304561387
Prevalence,Global,Female,65 to 69,Ischemic heart disease,Percent,2017,0.0629877489345,0.0695433908661,0.0571938170734
Prevalence,Global,Male,70 to 74,Ischemic heart disease,Percent,2017,0.115542761868,0.12832416213,0.102627592305
Prevalence,Global,Female,70 to 74,Ischemic heart disease,Percent,2017,0.0855236535083,0.0951258024339,0.0759409708607
Prevalence,Global,Male,75 to 79,Ischemic heart disease,Percent,2017,0.147509891538,0.163088903874,0.131478855019
Prevalence,Global,Female,75 to 79,Ischemic heart disease,Percent,2017,0.113511307173,0.125661965043,0.101376123407
Prevalence,Global,Male,80 plus,Ischemic heart disease,Percent,2017,0.167751545441,0.189543487667,0.148779319428
Prevalence,Global,Female,80 plus,Ischemic heart disease,Percent,2017,0.130742928217,0.147192299457,0.115812282714
Prevalence,Global,Male,10 to 14,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,10 to 14,Hypertensive heart disease,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,15 to 19,Hypertensive heart disease,Percent,2017,7.03058665615e-07,1.22603471629e-06,3.36363337324e-07
Prevalence,Global,Female,15 to 19,Hypertensive heart disease,Percent,2017,6.31553587488e-07,1.10290393017e-06,3.00380346068e-07
Prevalence,Global,Male,10 to 14,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,10 to 14,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,15 to 19,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,15 to 19,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,20 to 24,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,20 to 24,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,25 to 29,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,25 to 29,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,30 to 34,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,30 to 34,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,35 to 39,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Female,35 to 39,Alzheimer's disease and other dementias,Percent,2017,0.0,0.0,0.0
Prevalence,Global,Male,40 to 44,Alzheimer's disease and other dementias,Percent,2017,5.73862451254e-05,9.56639600762e-05,3.00767170695e-05
Prevalence,Global,Female,40 to 44,Alzheimer's disease and other dementias,Percent,2017,6.1469028573e-05,0.000100504801927,3.2941820136e-05
Prevalence,Global,Male,45 to 49,Alzheimer's disease and other dementias,Percent,2017,0.00042174026372,0.000618363753289,0.000282867585705
Prevalence,Global,Female,45 to 49,Alzheimer's disease and other dementias,Percent,2017,0.000450646507481,0.000656963527203,0.000304191862966
Prevalence,Global,Male,50 to 54,Alzheimer's disease and other dementias,Percent,2017,0.00127159927302,0.00170545473664,0.00091678162127
Prevalence,Global,Female,50 to 54,Alzheimer's disease and other dementias,Percent,2017,0.00135315838379,0.00179908417082,0.00098470383843
Prevalence,Global,Male,55 to 59,Alzheimer's disease and other dementias,Percent,2017,0.00289470956766,0.00362044893099,0.00223738928178
Prevalence,Global,Female,55 to 59,Alzheimer's disease and other dementias,Percent,2017,0.00309856610546,0.00388369574134,0.00241905040644
Prevalence,Global,Male,60 to 64,Alzheimer's disease and other dementias,Percent,2017,0.00682478479708,0.00867792095892,0.00544756111992
Prevalence,Global,Female,60 to 64,Alzheimer's disease and other dementias,Percent,2017,0.00747126528576,0.00950804884192,0.00596894090304
Prevalence,Global,Male,65 to 69,Alzheimer's disease and other dementias,Percent,2017,0.014392724934,0.017701741222,0.0116142338971
Prevalence,Global,Female,65 to 69,Alzheimer's disease and other dementias,Percent,2017,0.0159524549084,0.0195571314172,0.0128572771461
Prevalence,Global,Male,70 to 74,Alzheimer's disease and other dementias,Percent,2017,0.0294866853404,0.0358041516862,0.0239804321427
Prevalence,Global,Female,70 to 74,Alzheimer's disease and other dementias,Percent,2017,0.0332859734449,0.0404196142199,0.0270612617595
Prevalence,Global,Male,75 to 79,Alzheimer's disease and other dementias,Percent,2017,0.0597812871003,0.0738276030835,0.0478276491938
Prevalence,Global,Female,75 to 79,Alzheimer's disease and other dementias,Percent,2017,0.0688405585125,0.0848411683399,0.0551252066781
Prevalence,Global,Male,80 plus,Alzheimer's disease and other dementias,Percent,2017,0.14687146508,0.1719469833,0.123908413528
Prevalence,Global,Female,80 plus,Alzheimer's disease and other dementias,Percent,2017,0.185366011367,0.215830923757,0.15822392545
